Senti BiosciencesSNTI
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$2.11avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was 8VC GP I, LLC ($535K).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| 8VC GP I, LLC | 0.53% | No change | 253,755 | $535K |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.